Kenneth J. Tack

Direttore Tecnico/Scientifico/R&S presso NB Therapeutics

Health Technology

Consumer Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Joaquin Duato	M	61	JOHNSON & JOHNSON	35 anni
Brian M. Gallagher	M	76	NB Therapeutics NB Therapeutics Pharmaceuticals: MajorHealth Technology NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA.	-
Jeffrey O'Donnell	M	64	NB Therapeutics NB Therapeutics Pharmaceuticals: MajorHealth Technology NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA.	-
Zev S. Scherl	M	-	NB Therapeutics NB Therapeutics Pharmaceuticals: MajorHealth Technology NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA.	-
Michael Harrington	M	-	NB Therapeutics NB Therapeutics Pharmaceuticals: MajorHealth Technology NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA.	-
Marcus Schabacker	M	60	NB Therapeutics NB Therapeutics Pharmaceuticals: MajorHealth Technology NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA.	-
Kathryn Wengel	F	58	JOHNSON & JOHNSON	36 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Russell C. Deyo	M	74	JOHNSON & JOHNSON	27 anni
Alex Gorsky	M	63	JOHNSON & JOHNSON	35 anni
John Johnson	M	66	JOHNSON & JOHNSON	19 anni
Michael H. Ullmann	M	66	JOHNSON & JOHNSON	33 anni
Jack L. Bowman	M	91	JOHNSON & JOHNSON	7 anni
Martin Madden	M	64	JOHNSON & JOHNSON	31 anni
Tom Manion	M	70	JOHNSON & JOHNSON	8 anni
Gérard Vaillant	M	82	JOHNSON & JOHNSON	17 anni
JoAnn Heffernan Heisen	F	74	JOHNSON & JOHNSON	-
Angelo Scopelianos	M	69	JOHNSON & JOHNSON	24 anni
Jack Goldstein	M	77	JOHNSON & JOHNSON	11 anni
Robert Wills	M	70	JOHNSON & JOHNSON	26 anni
Patrick W. McNallen	M	-	JOHNSON & JOHNSON	2 anni
Andrea J. Casper	F	-	JOHNSON & JOHNSON	-
Manuel Aguero	M	62	JOHNSON & JOHNSON	6 anni
Davide Gallotti	M	65	JOHNSON & JOHNSON	5 anni
Nevin Grinnell	M	-	JOHNSON & JOHNSON	3 anni
Michael O'Neill	M	64	JOHNSON & JOHNSON	-
Miguel Patricio	M	57	JOHNSON & JOHNSON	6 anni
Don Casey	M	64	JOHNSON & JOHNSON	-
Linwood A. Staub	M	62	JOHNSON & JOHNSON	-
Gary Pruden	M	62	JOHNSON & JOHNSON	32 anni
Robert Gussin	M	86	JOHNSON & JOHNSON	14 anni
Patrick M. Lonergan	M	89	JOHNSON & JOHNSON	30 anni
Mario Thomas	M	73	JOHNSON & JOHNSON	8 anni
Ron Hunt	M	59	JOHNSON & JOHNSON	7 anni
David Anderson	M	71	JOHNSON & JOHNSON	6 anni
John Steven Sonnier	M	-	JOHNSON & JOHNSON	7 anni
Bruno A. Melzi	M	76	JOHNSON & JOHNSON	10 anni
Thomas M. Tully	M	78	JOHNSON & JOHNSON	8 anni
Dan Eckert	M	59	JOHNSON & JOHNSON	2 anni
David E. Collins	M	89	JOHNSON & JOHNSON	26 anni
Mark Adams	M	62	JOHNSON & JOHNSON	3 anni
Jean-Luc Butel	M	67	JOHNSON & JOHNSON	6 anni
George A. Ziets	M	77	JOHNSON & JOHNSON	7 anni
Maximillian D. Fiore	M	69	JOHNSON & JOHNSON	4 anni
Syed M. J. Kazmi	M	67	JOHNSON & JOHNSON	7 anni
Marvin L. Miller	M	87	JOHNSON & JOHNSON	3 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	45	100.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni